GALLANT 7 Tesaglitazar Add-on to Sulphonylurea

PHASE3TerminatedINTERVENTIONAL
Enrollment

555

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

March 31, 2006

Conditions
Type 2 Diabetes
Interventions
DRUG

Tesaglitazar 0.5 or 1 mg

DRUG

Glibenclamide 2.5, 5, 10 or 15 mg

Trial Locations (84)

Unknown

Research Site, Adelaide

Research Site, Brisbane

Research Site, Cairns

Research Site, Geelong

Research Site, Melbourne

Research Site, Perth

Research Site, Sydney

Research Site, Tasmania

Research Site, Angers

Research Site, Hyères

Research Site, La Garde

Research Site, La Seyne-sur-Mer

Research Site, Laval

Research Site, Le Brusc

Research Site, Le Lavandou

Research Site, Montrevault

Research Site, Paris

Research Site, Saint-Cyr

Research Site, Six-Fours-les-Plages

Research Site, Tiercé

Research Site, Toulon

Research Site, Ashkelon

Research Site, Haifa

Research Site, Holon

Research Site, Jerusalem

Research Site, Rishon LeZiyyon

Research Site, Safed

Research Site, Tel Aviv

Research Site, Tel Litwinsky

Research Site, Bergen

Research Site, Elverum

Research Site, Enebakk

Research Site, Fredrikstad

Research Site, Gamle Fredrikstad

Research Site, Hamar

Research Site, Haugesund

Research Site, Hurdal

Research Site, Inderøy

Research Site, Lena

Research Site, Levanger

Research Site, Oslo

Research Site, Rud

Research Site, Sedsmokorset

Research Site, Soerumsand

Research Site, Stavanger

Research Site, Manila

Research Site, Marikina City

Research Site, Pasig

Research Site, Cape Town

Research Site, Chatsworth

Research Site, Gauteng

Research Site, Pretoria

Research Site, Seoul

Research Site, Suwon

Research Site, Alzira (Valencia)

Research Site, Barcelona

Research Site, Guissona (Lleida)

Research Site, Madrid

Research Site, San Sebastian de Los Reyes ( Madrid)

Research Site, San Vicente de Raspeig (Alicante)

Research Site, Valencia

Research Site, Dublin

Research Site, Aberdeen

Research Site, Barnsley

Research Site, Bath

Research Site, Belfast

Research Site, Birmingham

Research Site, Cardiff

Research Site, Coventry

Research Site, Dundee

Research Site, East Sussex

Research Site, Edinburgh

Research Site, Glasgow

Research Site, Leeds

Research Site, Liverpool

Research Site, London

Research Site, Manchester

Research Site, Shrewsbury

Research Site, Surrey

Research Site, West Midlands

Research Site, Wiltshire

Research Site, Wrexham

Research Site, Hanoi

Research Site, Ho Chi Minh City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY